文章摘要 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Sirolimus-Eluting Stent: Randomized Substudy of the I-LOVE-IT 2 Trial
Novel predictor of target vessel revascularization after coronary stent implantation: Intraluminal intensity of blood speckle on intravascular ultrasound
Catastrophic catheter-induced coronary artery vasospasm successfully rescued using intravascular ultrasound imaging guidance
Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial
Impact of intravascular ultrasound on the long-term clinical outcomes in the treatment of coronary ostial lesions
IVUS in bifurcation stenting: what have we learned?
Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: the LANDMARK trial
Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries
Mechanical circulatory support devices for acute right ventricular failure

|<<... 82 83 84 85 86 87 88 ...>>|

Clinical Trial

November 10, 2018

JOURNAL：N Engl J Med.

Article Link

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

SD Wiviott，I Raz，DECLARE–TIMI 58 Investigators.

13479

Keywords: Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Prevention, Acute Heart Failure, Hypertension, Smoking

FULL TEXT PDF